Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12129249 Method for producing optically active compound

Patent 12129249 was granted and assigned to Day One Biopharmaceuticals on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Day One Biopharmaceuticals

Current Assignee

Day One Biopharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121292490

Patent Inventor Names

Yoshiyuki Takeda0

Sayuri Hirano0

Jun-ichi Kawakami0

Koji Nakamoto0

Motoki Ikeuchi0

Masato Kitayama0

Masatoshi Yamada0

Date of Patent

October 29, 2024

Patent Application Number

171801270

Date Filed

February 19, 2021

Patent Citations

‌

US Patent 9556177 Substituted 1,3-thiazoles as synthetic intermediates for preparation of Raf kinase inhibitors

‌

US Patent 7709500 Chemical compounds

‌

US Patent 7968536 Heterocyclic compounds useful as RAF kinase inhibitors

‌

US Patent 9238667 Rhodium catalyst and method for producing amine compound

‌

US Patent 10988469 Method for producing optically active compound

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12129249 Method for producing optically active compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API